XML 29 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
3. CAPITAL STOCK (Details Narrative) (USD $)
6 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2012
Mar. 31, 2013
Sep. 30, 2012
Mar. 31, 2013
Conversion of convertible securities by holder of Securities Purchase Agreement
Mar. 31, 2013
Common stock issued for an extension fee on a promissory note
Mar. 31, 2013
Conversion of convertible securities by holder of an exchange note
Mar. 31, 2013
Common stock issued in accordance with the settelment claim with Ironridge Global IV, Ltd
Sep. 30, 2012
Common stock issued in accordance with the settelment claim with Ironridge Global IV, Ltd
Common stock, shares authorized   500,000,000 500,000,000          
Preferred stock, shares authorized   50,000,000 50,000,000          
Preferred stock, par value   $ 0.01 $ 0.01          
Common stock issued in note conversion, shares 7,000,000     19,086,303   9,351,407    
Note principal and interest settled/converted in transaction $ 205,565     $ 174,800   $ 79,738    
Issuance of common stock for commitment fees, shares         500,000      
Share price         $ 0.02      
Common stock issued in settlement of accounts payable claims             38,271,791 27,500,000
Accounts payable claims settled through issuance of common stock               494,561
Agent and attorney fees included in settlment               $ 54,317
Terms of provision for adjustment of settlement shares             The Stipulation provided for an adjustment in the total number of shares, which may be issuable to Ironridge based on a calculation period and formula for the transaction (“Adjustment Shares”). The calculation formula is defined as that number of consecutive trading days following the date on which the Initial Shares were issued (the “Issuance Date”) required for the aggregate trading volume of the Common Stock, as reported by Bloomberg LP, to exceed $2.5 million (the “Calculation Period”). Pursuant to the Stipulation, Ironridge would retain 1,500,000 shares of the Company’s Common Stock, plus that number of shares (the “Final Amount”) through the end of the Calculation Period with an aggregate value equal to (a) the sum of the Accounts Payable plus 8% agent fee and reasonable attorney fees through the end of the Calculation Period, (b) divided by 80% of the following: the volume weighted average price (“VWAP”) of the Common Stock over the length of the Calculation Period, as reported by Bloomberg, not to exceed the arithmetic average of the individual daily VWAPs of any five trading days during the Calculation Period.